Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

60%

6 of 10 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

Phase 1

4(40.0%)

Phase 3

4(40.0%)

Phase 2

2(20.0%)

10Total

Phase 1(4)

Phase 3(4)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06278077Phase 2Completed

Neurexan - a Clinical Trial in Short-Term Insomnia Patients

Role: lead

NCT02602275Phase 2Completed

Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands

Role: lead

NCT06192420Phase 3Completed

TRAUMED - a Clinical Trial in Acute Ankle Sprain

Role: lead

NCT01887678Phase 3Completed

Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee

Role: lead

NCT01702233Phase 3Completed

TRARO (Traumeel® S in Rotator Cuff Syndrome)-Study

Role: lead

NCT01703832Phase 1Completed

Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects

Role: lead

NCT01703819Phase 1Completed

Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects

Role: lead

NCT01921777Phase 1Completed

Effects of Traumeel®S Tablets on Recovery and Inflammatory Immune Response After Repeated Bouts of Exercise

Role: collaborator

NCT01066520Phase 3Completed

TAASS-Traumeel Ointment and Gel Compared With a Topical NSAID in Athletes With Acute Ankle Sprain

Role: lead

NCT01912469Phase 1Completed

Effects of Traumeel®S Tablets on Exercise Induced Muscle Damage and Muscle Soreness

Role: collaborator

All 10 trials loaded